Clinical Trial Update: Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of adding ginsenoside Rg3 to first-line chemotherapy in advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Ginsenoside Rg3 (ginsenoside Rg3)

Snippet

Sponsor: Hebei Tumor Hospital | Conditions: Self Efficacy | Phase 2 | Status: UNKNOWN